检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]青岛大学医学院附属烟台毓璜顶医院心血管内科,山东烟台264000
出 处:《医学综述》2014年第17期3151-3153,共3页Medical Recapitulate
基 金:山东省优秀中青年科学家科研奖励基金项目(BS2009YY029)
摘 要:心肌无复流(MNR)现象是再灌注治疗(包括经皮冠状动脉介入术)后的常见并发症,其发生率为20%~70%,与临床预后密切相关。目前MNR的发生机制尚不明确,大量研究表明炎症-氧化应激参与MNR的发生、发展。缺血后适应具有与缺血预适应类似的心脏保护作用,缺血预适应可以抑制炎症-氧化应激反应。该文主要对心肌无复流的炎症-氧化应激机制及缺血后适应对炎症-氧化应激机制的抑制作用进行综述。The myocardial no reflow (MNR) phenomenon, the incidence of which is 20-70%, is a common complication of the reperfusion therapy ( including percutaneous coronary interention ) , and it is closely related to the clinical prognosis. At present, the mechanism of MNR is unclear, though a large number of studies have shown that inflammation and oxidative stress play a key role in the occurrence, development of MNR. Isehemia posteonditioning could have almost the same heart protection with preconditioning. Studies have shown that isehemie preconditioning can inhibit the inflammation-oxidative stress reaction. Our review will probe into the mechanism of inflammation-oxldative stress of MNR and the inhibition of isehemie postconditioning on inflammation-oxidative stress.
分 类 号:R542.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.46